RFG
TEVA icon

RFP Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

RFP Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-336
Closed -$5.46K – 718
2024
Q2 		$5.46K Sell
336
-28
-8% -$431 ﹤0.01% 544
2024
Q1 		$5.14K Buy
364
+245
+206% +$3.09K ﹤0.01% 524
2023
Q4 		$1.24K Hold
119
– – ﹤0.01% 750
2023
Q3 		$1.21K Hold
119
– – ﹤0.01% 748
2023
Q2 		$896 Hold
119
– – ﹤0.01% 837
2023
Q1 		$1.05K Hold
119
– – ﹤0.01% 629
2022
Q4 		$1.08K Buy
+119
New +$1.04K ﹤0.01% 762

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

RFP Financial Group's TEVA Position: Q3 2024 in Review

RFP Financial Group sold out of Teva Pharmaceuticals (TEVA) in Q3 2024, closing a stake of 336 shares — an estimated $5.46K sold.

RFP Financial Group first reported a position in TEVA in Q4 2022 and held it in 7 quarters. The position peaked at $5.46K in Q2 2024. 542 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • RFP Financial Group reported no remaining Teva Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • RFP Financial Group sold 336 Teva Pharmaceuticals shares in Q3 2024, an estimated $5.46K.
  • RFP Financial Group first reported a position in Teva Pharmaceuticals in Q4 2022 and held it in 7 quarters.
  • RFP Financial Group's Teva Pharmaceuticals position peaked at $5.46K in Q2 2024.
  • 542 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.